GPC1 and pancreatic neoplasm: In order to prevent the interference of other non-specific exosomes and make the detection result more accurate, Zhang et al. developed a microfluidic device HBEXO-Chip to isolate exosomes of the pancreatic cancer target Glypican-1 (GPC1) antibody [51].